LQ3 Pharmaceuticals, Inc. — Form D/A
LQ3 Pharmaceuticals, Inc. of MORRISVILLE, NC, a company, filed a Form D amendment with the SEC on 2014-12-17. The offering totals $10.0M, of which $2.4M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2014-12-17
- Form: D/A
- Accession: 0001614268-14-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $2.4M
- Remaining: $7.6M
- Investors: 4
- Date of first sale: 2014-07-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-221630
Issuer
- Name: LQ3 Pharmaceuticals, Inc.
- CIK: 0001614268
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 419 DAVIS DRIVE, MORRISVILLE, NC, 27560
- Phone: 919.328.4377
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Stephen Bloch | Director | Parsippany, NJ |
| KYLE CHENET | Director | Durham, NC |
| Neal Fowler | Director | DURHAM, NC |
| Seth Rudnick | Director | DURHAM, NC |
| Tim Albury | Executive Officer | MORRISVILLE, NC |
| KYLE CHENET | Executive Officer | Durham, NC |
| Shawn Glidden | Executive Officer | MORRISVILLE, NC |
| KYLE CHENET | Promoter | Durham, NC |
Other filings by this issuer (1)
More